Dysmenorrhea is painfully prevalent among modern women who are limiting numbers of pregnancies and the time they spend breastfeeding. In a study of college students, 84% of those surveyed reported having experienced dysmenorrhea; only 9% missed exams due to dysmenorrhea, but 48.7% reported poor satisfaction with their academic performance because of menstrual pain. Even though dysmenorrhea is an ancient Greek word, dysmenorrhea has only recently been recognized as a medical problem. Before the 1970s, there were virtually no scientific articles studying any aspect of the condition. The latest Canadian Society of Obstetrics and Gynecology guidelines report that both primary and secondary dysmenorrhea are likely to respond to the same medical therapies, so initiation of therapy should not depend on establishing a precise diagnosis. However, the choice of therapy should reflect the desire for fertility.
Let’s face it. Contraceptive failure is the norm when measured over users’ reproductive life spans. The typical woman who uses reversible methods of contraception continuously from age 15 to age 45 would experience 1.8 contraceptive failures, according to James Trussell and colleagues. Of course, every provider knows that what matters most is correct and consistent use. But then again, technology fails people just as people fail technology. While we understand that women may not see contraceptive efficacy as their priority in selecting a method, they still need to have accurate information about efficacy. Unfortunately, provider bias often distorts the accuracy of what patients are told. And often, providers do not always include information on the factors that can make patients’ use of their chosen method more or less effective for them personally.
Can you stop her flooding? About 30% of women report heavy menstrual bleeding (HMB). For many of them, that flooding is chronic. There are several treatment options for chronic HMB, but how do they compare over the long run? Any treatment needs to account for the age of the patient, the severity of symptoms, the presence of other pelvic pathology, and near-term plans for childbearing. Which are the clear front-runners in the treatment strategy? And what about new therapies coming down the pipeline?
Now available in a new 21st edition, this well-known text with more than 2 million copies in print has been the leading family planning resource... Read more
The Contraceptive Technology conferences will help you synthesize the data and translate the evidence into clinical “pearls” you can put directly into practice. With an array of Preconferences delving into selected specialty areas of interest, plenary sessions focusing on the “hottest” topics, a thought-provoking luncheon presentation, and 30 dynamic, interactive Concurrent Sessions, including hands-on workshops…this conference is certain to improve your clinical practice and expand your network of colleagues. Read more